Trim28 Contributes to EMT via Regulation of E-Cadherin and N-Cadherin in Lung Cancer Cell Lines

por Chen, Lu, Muñoz-Antonia, Teresita, Cress, W. Douglas
Publicado 2014

Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes

por Hudson, Janella, Munoz-Antonia, Teresita, Haura, Eric, Cress, Doug, Simmons, Vani N., Quinn, Gwendolyn P.
Publicado 2016

Aberrant Methylation Inactivates Transforming Growth Factor β Receptor I in Head and Neck Squamous Cell Carcinoma

por Muñoz-Antonia, Teresita, Torrellas-Ruiz, Mariclara, Clavell, Jonathan, Mathews, Linda A., Muro-Cacho, Carlos A., Báez, Adriana
Publicado 2009

Transforming Growth Factor β Signaling Overcomes Dasatinib Resistance in Lung Cancer

por Gordian, Edna, Li, Jiannong, Pevzner, Yuri, Mediavilla-Varela, Melanie, Luddy, Kimberly, Ohaegbulam, Kim, Daniel, Kenyon G., Haura, Eric B., Muñoz-Antonia, Teresita
Publicado 2014

Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer

por Gordian, Edna, Welsh, Eric A., Gimbrone, Nicholas, Siegel, Erin M., Shibata, David, Creelan, Ben C., Cress, William Douglas, Eschrich, Steven A., Haura, Eric B., Muñoz-Antonia, Teresita
Publicado 2019

Correction: Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer

por Gordian, Edna, Welsh, Eric A., Gimbrone, Nicholas, Siegel, Erin M., Shibata, David, Creelan, Ben C., Cress, William Douglas, Eschrich, Steven A., Haura, Eric B., Muñoz-Antonia, Teresita
Publicado 2021

Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model

por Sarcar, Bhaswati, Gimbrone, Nicholas T., Wright, Gabriela, Remsing Rix, Lily L., Gordian, Edna R., Rix, Uwe, Chiappori, Alberto A., Reuther, Gary W., Santiago‐Cardona, Pedro G., Muñoz‐Antonia, Teresita, Cress, William Douglas
Publicado 2019

ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

por Yoshida, Takeshi, Song, Lanxi, Bai, Yun, Kinose, Fumi, Li, Jiannong, Ohaegbulam, Kim C., Muñoz-Antonia, Teresita, Qu, Xiaotao, Eschrich, Steven, Uramoto, Hidetaka, Tanaka, Fumihiro, Nasarre, Patrick, Gemmill, Robert M., Roche, Joëlle, Drabkin, Harry A., Haura, Eric B.
Publicado 2016

Early2 factor (E2F) deregulation is a prognostic and predictive biomarker in lung adenocarcinoma

por Chen, Lu, Kurtyka, Courtney A, Welsh, Eric A, Rivera, Jason I, Engel, Brienne E, Muñoz-Antonia, Teresita, Yoder, Sean J, Eschrich, Steven A, Creelan, Ben C, Chiappori, Alberto A, Gray, Jhanelle E, Ramirez, Jose Luis, Rosell, Rafael, Schabath, Matthew B, Haura, Eric B, Chen, Dung-Tsa, Cress, Douglas W
Publicado 2016

Hyper-phosphorylation of Rb S249 together with CDK5R2/p39 overexpression are associated with impaired cell adhesion and epithelial-to-mesenchymal transition: Implications as a pote...

por Pérez-Morales, Jaileene, Mejías-Morales, Darielys, Rivera-Rivera, Stephanie, González-Flores, Jonathan, González-Loperena, Mónica, Cordero-Báez, Fernando Y., Pedreira-García, Wilfredo M., Chardón-Colón, Camille, Cabán-Rivera, Jennifer, Cress, W. Douglas, Gordian, Edna R., Muñoz-Antonia, Teresita, Cabrera-Ríos, Mauricio, Isidro, Angel, Coppola, Domenico, Rosa, Marilin, Boyle, Theresa A., Izumi, Victoria, Koomen, John M., Santiago-Cardona, Pedro G.
Publicado 2018

A community‐based lung cancer rapid tissue donation protocol provides high‐quality drug‐resistant specimens for proteogenomic analyses

por Boyle, Theresa A., Quinn, Gwendolyn P., Schabath, Matthew B., Muñoz‐Antonia, Teresita, Saller, James J., Duarte, Luisa F., Hair, Laura S., Teer, Jamie K., Chiang, Derek Y., Leary, Rebecca, Wong, Connie C., Savchenko, Alexander, Singh, Angad P., Charette, LaSalette, Mendell, Kate, Gorgun, Gullu, Antonia, Scott J., Chiappori, Alberto A., Creelan, Benjamin C., Gray, Jhanelle E., Haura, Eric B.
Publicado 2019